Literature DB >> 14520181

Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students.

Craig M Roberts1, John R Pfister, Scott J Spear.   

Abstract

UNLABELLED: A retrospective review of genital herpes simplex virus (HSV) isolates collected in a university student health service over a 9-year period showed that an increasing proportion of isolates were HSV-1 rather than HSV-2. HSV-1 accounted for 78% of all genital isolates in this population by 2001, compared with 31% of isolates in 1993.
BACKGROUND: Herpes simplex virus (HSV) type 1 is usually thought to cause less than 30% of genital herpes infections in the United States, but the proportion of infections resulting from HSV-1 is increasing in some populations. GOAL: The goal was to review the relative proportion of HSV-1 and HSV-2 as the cause of newly diagnosed genital herpes infections in a population of U.S. college students and to assess trends in the change of this proportion over time. STUDY
DESIGN: Genital HSV isolates collected at a university student health service from 1993 to 2001 (n = 499) were reviewed retrospectively. Analyses included comparisons of isolates by HSV type, age group, and sex.
RESULTS: The proportion of newly diagnosed genital herpes infections resulting from HSV-1 increased from 31% in 1993 to 78% in 2001 (P <0.001, linear trend P <0.001). HSV-1 was more common in females than males, but increases were noted for both sexes. HSV-1 was more common in persons aged 16 to 21 than in persons aged 22 or older.
CONCLUSIONS: HSV-1 has become the most common cause of newly diagnosed genital herpes infections in this population of college students and reflects a reversal of the usual HSV-1/HSV-2 ratio.

Entities:  

Mesh:

Year:  2003        PMID: 14520181     DOI: 10.1097/01.OLQ.0000092387.58746.C7

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  102 in total

Review 1.  The growing epidemic of sexually transmitted infections in adolescents: a neglected population.

Authors:  Chelsea L Shannon; Jeffrey D Klausner
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

2.  Health related quality of life in genital herpes: a pilot comparison of measures.

Authors:  D N Fisman
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

3.  Should sexually transmitted disease clinics routinely offer serologic testing for genital herpes?

Authors:  Michael F Rein
Journal:  Curr Infect Dis Rep       Date:  2006-01       Impact factor: 3.725

4.  Genital HSV-1 infections.

Authors:  A Wald
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

Review 5.  Herpesvirus Entry Mediator and Ocular Herpesvirus Infection: More than Meets the Eye.

Authors:  Rebecca G Edwards; Richard Longnecker
Journal:  J Virol       Date:  2017-06-09       Impact factor: 5.103

6.  The scarlet H.

Authors:  David W Kimberlin
Journal:  J Infect Dis       Date:  2013-10-16       Impact factor: 5.226

7.  A Herpes Simplex Virus (HSV)-2 Single-Cycle Candidate Vaccine Deleted in Glycoprotein D Protects Male Mice From Lethal Skin Challenge With Clinical Isolates of HSV-1 and HSV-2.

Authors:  Clare Burn; Natalie Ramsey; Scott J Garforth; Steven Almo; William R Jacobs; Betsy C Herold
Journal:  J Infect Dis       Date:  2018-02-14       Impact factor: 5.226

8.  Effector CD4+ T-cell involvement in clearance of infectious herpes simplex virus type 1 from sensory ganglia and spinal cords.

Authors:  Alison J Johnson; Chin-Fun Chu; Gregg N Milligan
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

9.  Herpes simplex virus type 1 is the leading cause of genital herpes in New Brunswick.

Authors:  Richard Garceau; Danielle Leblanc; Louise Thibault; Gabriel Girouard; Manon Mallet
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

10.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.